Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.155
+0.025 (0.80%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Voyager Therapeutics Employees
Voyager Therapeutics had 172 employees as of December 31, 2024. The number of employees increased by 10 or 6.17% compared to the previous year.
Employees
172
Change (1Y)
10
Growth (1Y)
6.17%
Revenue / Employee
$465,122
Profits / Employee
-$377,919
Market Cap
174.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
VYGR News
- 19 days ago - Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025 - GlobeNewsWire
- 5 weeks ago - Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewsWire
- 6 weeks ago - Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - GlobeNewsWire
- 6 weeks ago - Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer's Disease - GlobeNewsWire
- 6 weeks ago - The Schall Law Firm Invites Shareholders With Losses In Voyager Therapeutics, Inc. To Join A Securities Fraud Investigation - Accesswire
- 7 weeks ago - Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire